Сancer Specialist France - François Fauchon


 At the University Pierre and Marie Curie Paris VI, Dr. FAUCHON MD where attended his medical course at the Faculty of Medicine Pitié Salpétriè, from 1972 to 1987, he defended his doctoral thesis at the university.

He obtained, during his medical studies, the inter-university diploma of Radiosurgery Stereotaxis (Pr Schlienger) and the competence in oncology




He has worked in many oncology centers in France, including La Salpétrière Hospital, the High Energy Center in Nice and CPRM Claude Bernard in Metz.


In 1985, he was appointed senior doctor of the Paris Hospitals, at the Pitié Salpétrière Hospital and took charge of a floor of the Oncology radiotherapy department.

He sets up bibliographic training cycles and teaches courses regularly at the Faculty of Medicine.


He is a member of numerous cooperative research groups, including the American Society of Radiation Therapy (ASTRO), as well as the European Society of Radiation Therapy (ESTRO), the European Society of Radiotherapy and the EORTC and ANOCEF.

He is a board member of the Breast and Colon Cancer Screening Society (APREMAS).

He has also taught at the inter-university neuro-oncology course.

 Dr. Fauchon sets up invasive stereotactic radiotherapy in 1993 in Nice and then in 2017 in Metz. In Nice, in 1993, he created a cooperative group with the Neurochirugical Cluster of L'Hôpital Pasteur (Professor Paquis, Pr Fontaine) and the Anti-Cancer Center, within a partnership agreement.


Installed since 1989 at the High Energy Radiotherapy Center in Nice, he participates in the introduction of high precision technologies, and the development of modern Radiotherapy.


Since 1990, Dr. Fauchon has been Senior Physician in Oncology at CHE.




Since 2003, he has been involved in the associative and pedagogical level. In 2010, Dr. Fauchon founded, and still chairs, the ADERTU Association (Website: https //  facebook: ADERTU-CHE) to promote cancer treatments, research, innovation, and education. in oncology.

He has funded numerous research projects through this association and a partnership with LVMH. In particular, it enabled the research laboratory of Valrose (Nice) to acquire a sorting automaton and culture of malignant glial cells. It also enabled the acquisition of equipment enabling the implementation of intraoperative MRI at Pasteur University Hospital (Nice).

It has also helped to support the setting up of national or international conferences (WALT in 2018 and MACC 2016-2019).


He is also a member of the APPAC Association, which helps psycho-oncological support for patients and their families.



Ph. CORNU, G. CHATELIER, F. FAUCHON et coll. Pronostic des médulloblastomes de l'adulte. Neurochir. 1990, 36, 218-224.


J. POISSON, J CHIRAS, F. FAUCHON, C. DEBUSSCHE, J.Y     DELATTRE. Treatment of malingnant recurrent glioma by intra-arterial, infraophtalmic infusion of HeCNU. A phase II study J. Neuro-onc 1990 ; 8 : 255-262


N. SICHEZ, F. FAUCHON, et Coll. Second meeting of the European Neurological Society. Brighton (U.K) 30 June - 5 July 1990. In J. Neur. 1990, 237 suppl 1. Quality of life in long term survivors of astrocytomas treated with surgery and radiation therapy: a neuropsychological study.


F. FAUCHON, L DAVILA, G. CHATELIER, D. FOHANNO, J. PHILIPPON, A. REY, J. CHIRAS, M. POISSON, and J.Y DELATTRE. Treatment of malignant gliomas with surgery, intra-arterial infusions of 1 ( 2 - hydroxyethyl) chloroethylnitrosourea and radiation therapy: a phase II study. Neurosurg. 1990, 27, 2,231-234.


J. PINTO, M. JEANDON, M. MORO et F. FAUCHON. Cancer de l'endomètre stade I et II (FIGO 1988) Société Française des physiciens d'hôpitaux Saint Etienne.(France) 2-3 décembre 1990.


F. FAUCHON et coll.  Pathologie médullaire. In TDM et IRM CLINIQUE. Neurologie, neurochirurgie, ophtalmologie, ORL et stomatologie. D. BUTHIAU. Ed. Frison-Roche,(1992) pp 517-538.


F. FAUCHON, G. DEFER, M. SCHAISON, J. CHIRAS, and P. BRUNET. Visual toxicity following intraarterial chemotherapy of HECNU in patients with malignant gliomas. Neuroradiol 1991, 33 : 432-437.


M. POISSON,  J. CHIRAS, F. FAUCHON et Coll Traitement des gliomes malins sustentoriels de l’adulte, par l’HECNU intra arteriel. Expérience du groupe Pitié Salpétrière. Rev. Neurol. 1992, 148, 411-447


P. PAQUIS, M. CHATEL, C. LEBRUN-FRENAY, J.F MICHIELS, F.FAUCHON Astrocytomes de bas grade. Encycl. Méd. Chir. (Elsevier, Paris) Neurologie, 17-2/0-B-20, 1996, 12P.


PHILIPPON J., CLEMENCEAU S., FAUCHON F., FONCIN JF. Supratentorial low grade astrocytomas in adults. Neurosurgery 1993, 32(4), 554-559.


P. COLIN , F. FAUCHON, A. JOUVET, P.PAQUIS, Gh. SAINT-PIERRE, C MOTTOLESE, M. BEN HASSEL, J. PHILIPPON, L. CHAUVEINC, J.P SICHEZ , J. PHILIPPON, M. SCHLIENGER ,E. BOUFFET. Radiothérapie stéréotaxique fractionnée : résultats dans les adénomes hypophysaires, les neurinomes de l’acoustique et les méningiomes du sinus caverneux  Cancer\Radiother. 2 : 207-214 ;1998


A. JOUVET, G. SAINT-PIERRE, F. FAUCHON,  K. PRIVAT,  E. BOUFFET,  M.M. RUCHOUX, L.CHAUVEINC, M. FEVRE-MONTANGE. Pineal parenchymal tumor : correlation of histological features with prognosis in 66 cases. Brain Pathology 10 : 49-60 ; 2000


F. FAUCHON, A. JOUVET, P. PAQUIS , Gh. SAINT-PIERRE, C. MOTTOLESE, M. BEN HASSEL, L. CHAUVEINC, J.P. SICHEZ, J. PHILIPPON, M. SCHLIENGER and E. BOUFFET. Parenchymal pineal tumors: a clinicopathological study of 76 cases. Int. J. Rad. Onc. Biol. Phys. 46 : 4, 959–968 ; 2000


J. LUTTERBACH, F. FAUCHON, S.E SCHILD, S.M. CHANG, A. PAGENSTECHER, B. VOLK, C. OSTERTAG, F. MOMM, A. JOUVET. Malignant pineal parenchymal tumors in adult patients. Neurosurgery 51 : 44-56 ;2002



Papillary tumors of the pineal region. American Journal of Surgical Pathology 2003.


M. MONTANGE, M. HASSELBLATT, D. FIGARELLA-BRANGER, L. CHAUVEINC, J. CHAMPIER, Gh. SAINT-PIERRE, L. TAILLANDIER, A.COULON, W.PAULUS, F.FAUCHON and A. JOUVET. Prognosis and histopathologic features in papillary tumors of the pineal region : a retrospective multicenter study of 31 cases. J Neuropathol Exp Neurol, 65, 10, 1004-1011, 2006.


F. FAUCHON ,  A.  JOUVET, C. ALAPETITE , M. BENHASSEL, C. MOTTOLESE, M. LONJON, M. FEVRE-MONTANGE .Traitement des tumeurs de la région pinéale (TRP) Expert Review of Neurotherapeutics. 2007.


FEVRE-MONTANGE M, SZATHMARI A, CHAMPIER J, MOKHTARI K, CHRETIEN F, COULON A, FIGARELLA-BRANGER D, POLIVKA M, VARLET P, URO-COSTE E, FAUCHON F, JOUVET A ; Pineocytoma and pineal parenchymal tumors of intermediate differentiation presenting cytologic pleomorphism: a multicenter study. Brain Pathol 2008 Jul;18(3):354-9


FEVRE-MONTANGE M, CHAMPIER J, SZATHMARI A, BRISSON C, REBOUL A, MOTTOLESE C, FAUCHON F, et al. Histological features and expression of enzymes implicated in melatonin synthesis in pineal parenchymal tumours and in cultured tumoural pineal cells. Neuropathol Appl Neurobiol 2008 Jun;34(3):296-305.


Martin Kocher, Riccardo Soffietti, Ufuk Abacioglu, Salvador Villa, Francois Fauchon, Brigitta G. Baumert , Laura Fariselli, Tzahala Tzuk-Shina,Rolf-Dieter Kortmann, Christian Carrie, Mohamed Ben Hassel, Mauri Kouri, Egils Valeinis, Guy Storme, Sandra Collette,Laurence Collette  and Rolf-Peter Mueller for the EORTC Radiation Oncology and Brain Tumor Groups Adjuvant Whole Brain Radiotherapy versus Observ Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: Quality-of-life results. Journal of Clinical Oncology. volume 31, issue 1, 2013, pp. 65 - 72.


There are no comments to display
You can leave a comment. Your e-mail will not be published.